Clinical Trials · NCT07845994
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University Hospital, Angers
- Enrollment
- 50
- Start date
- Nov 2026
- Locations
- 17 sites, France
- Primary endpoint
- Change in BMI SD score (according to french references) at 40 weeks